Latest Articles
Lisata Therapeutics CEO David Mazzo on Q3 results; updates on key clinical trials and partnerships - Proactive Investors UK
Lisata Therapeutics CEO David Mazzo on Q3 results; updates on key clinical trials and partnerships Proactive Investors UK
Published: Nov. 14, 2024, 4:39 p.m.
Lisata Therapeutics partners with University of Cincinnati to investigate endometriosis therapy - ICYMI - Proactive Investors USA
Lisata Therapeutics partners with University of Cincinnati to investigate endometriosis therapy - ICYMI Proactive Investors USA
Published: Nov. 2, 2024, noon
Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis - Proactive financial news
Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis Proactive financial news
Published: Oct. 28, 2024, 1:52 p.m.
Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis - Proactive Investors USA
Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis Proactive Investors USA
Published: Oct. 28, 2024, 1:52 p.m.
Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis - Proactive Investors Australia
Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis Proactive Investors Australia
Published: Oct. 28, 2024, 1:52 p.m.
Endometriosis Australia Partners with CHARLI App to Tackle Diagnosis Delays - Femtech Insider
Endometriosis Australia Partners with CHARLI App to Tackle Diagnosis Delays Femtech Insider
Published: April 5, 2024, 7 a.m.
SCA announces new charity partnerships - Radio Today (Aust & NZ)
SCA announces new charity partnerships Radio Today (Aust & NZ)
Published: Jan. 29, 2024, 8 a.m.
Link copied to clipboard!